A previous study indicated that high mRNA and protein levels of ezrin in clinical ovarian carcinoma (OC) specimens of malignant effusions were observed when compared to solid tumors, including primary tumors and solid metastases. This evidence concerns the gene EZR and ovarian carcinoma.